Graft Failure Clinical Trials

9 recruiting

Graft Failure Trials at a Glance

11 actively recruiting trials for graft failure are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Beijing, Amsterdam, and Cincinnati. Lead sponsors running graft failure studies include Peking University People's Hospital, Loma Linda University, and Children's Hospital Medical Center, Cincinnati.

Browse graft failure trials by phase

Treatments under study

About Graft Failure Clinical Trials

Looking for clinical trials for Graft Failure? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Graft Failure trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Graft Failure clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery

Graft FailureCoronary Artery BypassCoronary Artery Bypass Graft+1 more
University of Edinburgh70 enrolled1 locationNCT06800430
Recruiting

Vascular Complications After Kidney Transplantation

Heart FailureKidney Transplant; ComplicationsRenovascular Hypertension+4 more
University of Aarhus60 enrolled3 locationsNCT07531966
Recruiting
Phase 2

Allo HSCT for High Risk Hemoglobinopathies

Sickle Cell DiseaseHemoglobinopathiesGraft Failure
Masonic Cancer Center, University of Minnesota62 enrolled1 locationNCT06872333
Recruiting
Early Phase 1

Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients

Hematopoietic Stem Cell TransplantationGraft Failure
Children's Hospital Medical Center, Cincinnati20 enrolled1 locationNCT07244419
Recruiting
Phase 4

Pilot Trial of Colchicine for Graft Failure in CABG

Graft FailureCABGColchicine
Ruijin Hospital100 enrolled1 locationNCT06802926
Recruiting
Not Applicable

CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure

Graft FailurePoor Graft Function
NYU Langone Health21 enrolled1 locationNCT06569082
Recruiting

Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection

Graft FailureAcute Rejection of Renal Transplant
Loma Linda University150 enrolled1 locationNCT05084768
Recruiting
Not Applicable

Modified Second Haplo-transplantation for Graft Failure

Stem Cell Transplant ComplicationsGraft Failure
Peking University People's Hospital12 enrolled1 locationNCT06512545
Recruiting
Not Applicable

Second Haplo-transplantation for Graft Failure

Stem Cell Transplant ComplicationsGraft Failure
Peking University People's Hospital34 enrolled1 locationNCT06512519
Recruiting

Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease

Graft FailureRecurrent Angina After Coronary Artery Bypass GraftCoronary Artery Disease Progression
Amsterdam UMC, location VUmc500 enrolled1 locationNCT04772768
Recruiting

Effect of the remote ischemic preconditioning on primary graft failure after heart transplantation: A Randomized Controlled Trial

heart transplant rejectionprimary graft failure
Professor Igor E. Konstantinov50 enrolled1 locationACTRN12615001196538